Alan Leeb
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
- Health top 10%
- Vaccine Coverage and Hesitancy
Papers in
- Epidemiology 12
- Influenza Virus Research Studies 5
- Herpesvirus Infections and Treatments 4
- Virology and Viral Diseases 2
- Respiratory viral infections research 2
- Health 7
- Vaccine Coverage and Hesitancy 7
- Co-authors
- Kristine Macartney (9 shared papers)Patrick Cashman (8 shared papers)Alexis Pillsbury (6 shared papers)Helen Quinn (4 shared papers)Catherine Glover (7 shared papers)Annette K. Regan (2 shared papers)Tom Snelling (7 shared papers)Christopher C. Blyth (4 shared papers)
- Journals
- Vaccine (5 papers)BMJ Open (4 papers)The Medical Journal of Australia (3 papers)Vaccines (2 papers)Human Vaccines & Immunotherapeutics (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Alan Leeb
27 papers receiving 325 citations
Peers
Comparison fields: 5 of 44
- Toxicology 38
- Health 71
- Epidemiology 141
- Infectious Diseases 70
- Applied Microbiology and Biotechnology 4
Countries citing papers authored by Alan Leeb
This map shows the geographic impact of Alan Leeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Leeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Leeb more than expected).
Fields of papers citing papers by Alan Leeb
This network shows the impact of papers produced by Alan Leeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Leeb. The network helps show where Alan Leeb may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Leeb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 44 | |
| 2 | 2018 | 38 | |
| 3 | 2015 | 31 | |
| 4 | 2017 | 31 | |
| 5 | 2020 | 18 | |
| 6 | 2020 | 17 | |
| 7 | 2022 | 16 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 13 | |
| 10 | 2016 | 13 | |
| 11 | 2021 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2021 | 10 | |
| 14 | 2022 | 10 | |
| 15 | 2020 | 9 | |
| 16 | 2011 | 8 | |
| 17 | 2020 | 7 | |
| 18 | 2021 | 7 | |
| 19 | 2024 | 5 | |
| 20 | 2019 | 4 |
About Alan Leeb
Alan Leeb is a scholar working on Epidemiology, Health, Infectious Diseases, Immunology and Allergy and Immunology, having authored 28 papers that have together received 330 indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (7 papers), Influenza Virus Research Studies (5 papers), Herpesvirus Infections and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Virology and Viral Diseases (2 papers), Respiratory viral infections research (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Food Allergy and Anaphylaxis Research (2 papers). The work is most often cited by research in Toxicology (38 citations), Health (71 citations), Epidemiology (141 citations), Infectious Diseases (70 citations) and Applied Microbiology and Biotechnology (4 citations). Alan Leeb has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Kristine Macartney, Patrick Cashman, Alexis Pillsbury, Helen Quinn, Catherine Glover, Annette K. Regan, Tom Snelling, Christopher C. Blyth, Parveen Fathima and Nicholas Wood. Their work appears in journals such as Vaccine, BMJ Open, The Medical Journal of Australia, Vaccines and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.